Predictors of MTX monotherapy treatment success among patients with RA include low disease activity, normal body weight and ESR levels, and fewer tender joints.

HealthDay News — Chronic kidney disease (CKD) cases and deaths in women surged worldwide between 1990 and 2021, according to a study presented at Kidney Week, the annual meeting of the American ...

Vasomotor symptoms (VMS) during the menopause transition (MT) are associated with an increased risk for type 2 diabetes (T2D).

In patients with migraine, erenumab was safe and tolerable and effectively reversed migraine deterioration during treatment pauses.

SHBG levels were inversely associated with fracture risk among men, whereas testosterone demonstrated a non-linear relationship.

Data from the SENZA-PDN trial showed 10 kHz SCS yielded long-term, clinically meaningful reductions in HbA1c and weight in patients with PDN and T2D.

HealthDay News — There is a dose-dependent association for smoking and cardiovascular disease (CVD) risk, according to a study published online Nov. 1 in JAMA Network Open.

The FDA has expanded the approval of Jylamvo (methotrexate) to include the treatment of pediatric patients with acute lymphoblastic leukemia.

Roxybond (oxycodone hydrochloride) immediate-release 10mg tablet for the management of pain severe enough to require an opioid analgesic.

(HealthDay News) — The “weekend warrior” physical activity pattern is associated with a reduced risk for mild dementia over time, according to a study published online Oct. 29 in the British Journal ...

Total hip replacement results in superior reduction in hip pain and improved hip function at six months compared with resistance training among patients aged 50 years or older with severe hip ...

Ixekizumab and apremilast may be an effective treatment among patients with genital psoriasis, with improved disease response and clearance rates.